These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2458573)

  • 1. Analgesic and cardiovascular effects of centrally administered substance P.
    Clint BD; Lipton JM; Giesecke AH
    Peptides; 1988; 9(3):619-23. PubMed ID: 2458573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tachykinin receptor subtype. Central cardiovascular regulation of tachykinin peptides.
    Takano Y; Nagashima A; Hagio T; Nakayama Y; Kamiya H
    Ann N Y Acad Sci; 1991; 632():476-8. PubMed ID: 1719908
    [No Abstract]   [Full Text] [Related]  

  • 3. Central action of PGE1 on the cerebral neurotransmission; the cardiovascular response.
    Krzemiński T; Kurcok A; Brus R
    Biomed Biochim Acta; 1988; 47(10-11):S328-32. PubMed ID: 2854731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of centrally administered peptides on ear withdrawal from heat in the rabbit.
    Williams DW; Lipton JM; Giesecke AH
    Peptides; 1986; 7(6):1095-100. PubMed ID: 2882494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [On the relation between substance P and physostigmine on cardiovascular control in rabbit brain].
    Yang LP; Wen ZY; Yu GQ; Tian H
    Sheng Li Xue Bao; 1992 Apr; 44(2):192-6. PubMed ID: 1377837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Noradrenaline is involved in cardiovascular responses induced by intracerebroventricular injection substance P in rabbits].
    Qian H; Yang LP; Liu AD; Tian H; Wei ZY
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2004 Aug; 20(3):254-8. PubMed ID: 21192418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of intraventricular injection of substance P on pulmonary and carotid arterial pressure in rabbits].
    Ni H; Zhang XH
    Sheng Li Xue Bao; 1993 Apr; 45(2):149-57. PubMed ID: 7689252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure response to intravenous noradrenaline is influenced by substance P in normotensive and hypertensive rabbits.
    Brattström A; Orlow G; Schälike W; Kreher C
    J Hypertens Suppl; 1986 Dec; 4(6):S230-3. PubMed ID: 2441014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analgesic activity of substance P in rats: apparent mediation by met-enkephalin release.
    Naranjo JR; Sánchez-Franco F; Garzón J; del Río J
    Life Sci; 1982 Feb; 30(5):441-6. PubMed ID: 6174842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular effects of substance P peptides in the nucleus of the solitary tract.
    Hall ME; Miley FB; Stewart JM
    Brain Res; 1989 Sep; 497(2):280-90. PubMed ID: 2479449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition by morphine of the cardiovascular and behavioral responses evoked by centrally administered substance P in conscious rats.
    Itoi K; Jost N; Tschöpe C; Culman J; Badoer E; Unger T
    Neuropharmacology; 1994 Feb; 33(2):181-7. PubMed ID: 7518572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central norepinephrine pathways are involved in cardiovascular response to intracerebroventricular substance P.
    Qian H; Yang LP; Wei ZY; Liu AD; Tian H; Yang SF
    Acta Pharmacol Sin; 2001 Apr; 22(4):349-54. PubMed ID: 11742588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal beta-funaltrexamine antagonizes intracerebroventricular beta-endorphin- but not morphine-induced analgesia in mice.
    Suh HH; Tseng LF
    J Pharmacol Exp Ther; 1988 May; 245(2):587-93. PubMed ID: 2966856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxytocin pathways mediate the cardiovascular and behavioral responses to substance P in the rat brain.
    Maier T; Dai WJ; Csikós T; Jirikowski GF; Unger T; Culman J
    Hypertension; 1998 Jan; 31(1 Pt 2):480-6. PubMed ID: 9453349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autonomic effects of central injections of D-Ala2-Met-enkephalinamide (DAME) in the conscious monkey.
    Owen MD; Gisolfi CV; Reynolds DG; Gurll NJ
    Peptides; 1984; 5(4):737-42. PubMed ID: 6494024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Centrally-induced vasopressor responses to sodium-potassium adenosine triphosphatase inhibitor, ouabain, may be mediated via angiotensin II in the anteroventral third ventricle in the brain.
    Takahashi H; Iyoda I; Takeda K; Sasaki S; Okajima H; Yamasaki H; Yoshimura M; Ijichi H
    Jpn Circ J; 1984 Nov; 48(11):1243-50. PubMed ID: 6094853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diverse effects of tachykinins on luteinizing hormone release in male rats: mechanism of action.
    Kalra PS; Sahu A; Bonavera JJ; Kalra SP
    Endocrinology; 1992 Sep; 131(3):1195-201. PubMed ID: 1380435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists.
    Picard P; Regoli D; Couture R
    Br J Pharmacol; 1994 May; 112(1):240-9. PubMed ID: 7518304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central effects of substance P and somatostatin in conscious, streptozotocin-treated rats.
    Tomlinson KC; Gardiner SM; Bennett T
    Am J Physiol; 1990 Sep; 259(3 Pt 2):R405-10. PubMed ID: 1697738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cardiovascular effects of centrally administered substance P in the anaesthetised rabbit.
    Petty M; Reid J
    Eur J Pharmacol; 1982 Aug; 82(1-2):9-14. PubMed ID: 6182007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.